Skip to main content
. Author manuscript; available in PMC: 2011 Apr 14.
Published in final edited form as: JAMA. 2008 Jun 18;299(23):2760–2769. doi: 10.1001/jama.299.23.2760

Figure 2.

Figure 2

Kaplan-Meier Prostate Cancer-Specific Survival (PCSS) Estimates at 10 Years

Survival rates are following recurrence in men who received no salvage therapy (ST) vs salvage radiotherapy (SRT; with or without hormonal therapy), stratified by prostate-specific antigen doubling time, surgical margin status, and postoperative Gleason score.